PLAU anticorps (C-Term)
(1 reference)-
- Antigène Voir toutes PLAU Anticorps
- PLAU (Plasminogen Activator, Urokinase (PLAU))
-
Épitope
- C-Term
-
Reactivité
- Humain
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PLAU est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Attributs du produit
- Purified IgG
- Purification
- Purified
- Immunogène
- Peptide with sequence C-HFLPWIRSHTKEEN from the C-terminal of the Urokinase sequence.
- Isotype
- IgG
- Top Product
- Discover our top product PLAU Anticorps primaire
-
anti-Plasminogen Activator, Urokinase (PLAU) (AA 60-90), (N-Term) antibody
PLAU Reactivité: Humain, Souris WB, IHC (p), FACS Hôte: Lapin Polyclonal RB04087 unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (C-Term) antibodyVerified PLAU Reactivité: Humain ELISA, IHC Hôte: Chèvre Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 396-426) antibodyPLAU Reactivité: Humain WB, ELISA, IHC, FACS, IF Hôte: Lapin Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 60-90) antibodyPLAU Reactivité: Humain, Souris WB, ELISA, IHC, FACS Hôte: Lapin Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 180-433) antibodyPLAU Reactivité: Souris WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 396-426), (C-Term) antibodyPLAU Reactivité: Humain WB, IHC (p), FACS, IF Hôte: Lapin Polyclonal RB04089-04090 unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) antibodyPLAU Reactivité: Humain WB, IHC (p) Hôte: Lapin Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 16-115) antibodyPLAU Reactivité: Humain WB, ELISA Hôte: Souris Monoclonal 3B8 unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 17-432) antibodyPLAU Reactivité: Rat WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 21-173) antibodyPLAU Reactivité: Humain WB, ELISA, IHC Hôte: Lapin Polyclonal unconjugated
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
-
-
: "uPA and uPAR in fibrinolysis, immunity and pathology." dans: Trends in immunology, Vol. 25, Issue 8, pp. 450-5, (2004) (PubMed).
-
: "uPA and uPAR in fibrinolysis, immunity and pathology." dans: Trends in immunology, Vol. 25, Issue 8, pp. 450-5, (2004) (PubMed).
-
- Antigène
- PLAU (Plasminogen Activator, Urokinase (PLAU))
- Autre désignation
- UROKINASE (PLAU Produits)
- Synonymes
- anticorps PLAU, anticorps u-PA, anticorps ATF, anticorps BDPLT5, anticorps QPD, anticorps UPA, anticorps URK, anticorps uPA, anticorps UPAM, anticorps plasminogen activator, urokinase, anticorps urokinase-type plasminogen activator, anticorps PLAU, anticorps CpipJ_CPIJ002131, anticorps CpipJ_CPIJ006543, anticorps CpipJ_CPIJ013396, anticorps CpipJ_CPIJ013623, anticorps Plau
- ID gène
- 5328
- UniProt
- P00749
- Pathways
- Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Autophagy, Smooth Muscle Cell Migration
-
